CLINICAL SUPPLY MANAGEMENT ARTICLES
The Last Mile Nobody Talks About: What Really Happens To Unused Clinical Trial Supplies
Unused clinical trial supplies present complex logistical and compliance challenges. Learn why returns, reconciliation, and forecasting matter after a study ends.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Since the FDA is now encouraging creativity in trial designs, it is important for all stakeholders to adapt processes to follow the science and ultimately bring medicines to patients, faster. This white paper addresses the complexities that come with these trial designs, and how randomization and trial supply management (RTSM) solutions are critical to run flexible, robust, and quality-driven trials.
-
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
Access the transcript from a recent Clinical Leader Live webinar where supply chain optimization experts shared best practices for streamlining shipments, reducing waste, and enhancing accountability.
-
Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
-
Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
-
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
Explore how biopharma organizations can design and operate clinical supply systems that absorb complexity while maintaining control and consistency.